STENOCARE´s milestones and achievements

The timeline is categorized into the four strategic investment areas:

Regulatory Assets:
Having licenses and product approvals from the Health Authorities to operate. This is a key requirement to legally do business.

Supply Chain  Assets:
Sourcing medical cannabis products that can secure supply capacity and scale across all the markets. This gives a strong and broad product portfolio to offer patients.

Commercial Assets:
Having sales channels and distribution logistics in multiple markets for prescription-based medical cannabis. With a broad access it is possible to benefit from the market growth.

Partnership Assets:
Working with pharma-grade partners to develop future medical cannabis products. This is a way to be active across the entire value chain and get traction faster.

February 2022

STENOCARE and their UK partners receive product approval of three medical cannabis oil products

Read more
February 2022

STENOCARE enters the UK market to sell prescription-based medical cannabis oil products

Read more
January 2022

STENOCARE announces positive outcome of feasibility study

Read more
January 2022

STENOCARE approved to supply Danish patients with medical cannabis oil products

Read more
November 2021

STENOCARE Danish investments on solid ground: Legalisation of medical cannabis in Denmark has been passed by the Danish Parliament

Read more
November 2021

Secure supply of premium products: STENOCARE sign supply agreement with AgMedica Bioscience Inc

Read more
September 2021

Having own capacity and quality compliance: STENOCARE completes the ambutious upgrade of their state-of-art cultivation facility in Denmark

Read more
February 2021

STENOCARE deliver the first prescription-based medical cannabis THC-CBD oil products to Sweden

Read more
December 2020

STENOCARE deliver the first prescription-based medical cannabis oil products to Sweden

Read more
September 2020

STENOCARE enter Sweden as the first and only supplier of medical cannabis THC oil products

Read more
June 2020

STENOCARE complete capital raise with DKK 51 mill to accelerate STENOCARE 2.0 strategy

Read more
May 2020

STENOCARE move to NASDAQ First North Copenhagen as the first medical cannabis company

Read more
March 2020

Secure supply of premium products: STENOCARE sign supply agreement with Israeli Panaxia Pharmaceutical Industries and submit product application for Denmark

Read more
February 2020

STENOCARE CEO comments on profitable Year-End Report 2019 and the road ahead

Read more
December 2019

Investment in exclusive products: STENOCARE sign partnership agreement with pharma product developer Solural Pharma with global exclusivity

Read more
November 2019

Secure supply of premium products: STENOCARE sign new supply agreement with Canadian Emerald Health Therapeutics

Read more
September 2019

STENOCARE completed first grow cycle of medical cannabis without use of pesticides

Read more
September 2019

STENOCARE terminate partnership agreement with Canadian supplier and stop selling their products in Denmark

July 2019

STENOCARE established in Ireland and at the same time medical cannabis is legalized in a five-year pilot programme

Read more
June 2019

STENOCARE start cultivating medical cannabis in their Danish facility

Read more
May 2019

STENOCARE is first to have medical cannabis capsules approved in Denmark

Read more
May 2019

STENOCARE is awarded "Best IPO 2018" on Spotlight Stock Market in Stockholm

Read more
March 2019

STENOCARE has become the market leader of medical cannabis in Denmark

Read more
October 2018

STENOCARE complete capital raise with DKK 18.6 mill to accelerate STENOCARE 1.0 strategy

Read more
October 2018

STENOCARE is the first medical cannabis supplier IPO in Europe. Trade on Spotlight Stock Market in Stockholm begin today

Read more
September 2018

STENOCARE start selling and delivering prescription-based medical cannabis oil products in Denmark

Read more
June 2018

First-mover: STENOCARE is the first to have medical cannabis oil products approved in Denmark

Read more
March 2018

STENOCARE is granted a license to import, package and sell medical cannabis products in Denmark

Read more
January 2018

STENOCARE sign partnership agreement with Canadian supplier to source products for Danish patients

January 2018

The Danish Pilot Programme for medical cannabis is live and treatment can commence

Read more
December 2017

STENOCARE is granted a license to cultivate medical cannabis in Denmark

Read more
October 2017

STENOCARE is incorporated by the three founders

Read more
August 2017

Danish Parliament decide to legalize medical cannabis in a four-year Pilot Programme

Read more